Back

P540
Assessment of cardioprotective properties of FSTL1 in vitro using human iPSC-derived cardiomyocytes

Cardiovascular Research

23 April 2018
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Doxorubicin-induced upregulation of follistatin-like 3 (FSTL3): a new therapeutic target
29 August 2022
thumbnail
Congress Presentation
A novel bioreactor platform to apply dynamic load to neonatal lamb living myocardial slices for the study of the regenerative properties of the heart
25 August 2023
thumbnail
Congress Presentation
Maturing hiPSC-cardiomyocytes in cardiac microtissues for accurate preclinical in vitro modelling of long-QT syndrome type 1
12 April 2024
thumbnail
Congress Presentation
Functional and transcriptional sequelae of cardiomyocyte telomere shortening and their pathologic relevance in dilated cardiomyopathy and ischemic heart failure
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources